American Journal of Kidney Diseases
Volume 52, Issue 2 , Pages 251-261 , August 2008

Racial Differences in the Competing Risks of Mortality and ESRD After Acute Myocardial Infarction

  • Britt B. Newsome, MD, MPH, MSPH

      Affiliations

    • Center for Outcomes Effectiveness Research and Education, University of Alabama at Birmingham, Birmingham, AL
    • Department of Medicine, Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL
    • Department of Medicine, Division of Nephrology, University of Alabama at Birmingham, Birmingham, AL
    • Corresponding Author InformationAddress correspondence to Britt B. Newsome, MD, MPH, MSPH, 1530 3rd Ave South, MT 401E2, Birmingham, AL 35294.
    • ,
  • William M. McClellan, MD, MPH

      Affiliations

    • Department of Medicine, Renal Division, Emory University School of Medicine, Atlanta, GA
    • ,
  • Jeroan J. Allison, MD, MS

      Affiliations

    • Center for Outcomes Effectiveness Research and Education, University of Alabama at Birmingham, Birmingham, AL
    • Department of Medicine, Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL
    • Department of Medicine, Division of General Internal Medicine, University of Alabama at Birmingham, Birmingham, AL
    • ,
  • Paul W. Eggers, PhD

      Affiliations

    • US Renal Data System, Bethesda, MD
    • ,
  • Shu-Cheng Chen, MS

      Affiliations

    • US Renal Data System, Bethesda, MD
    • ,
  • Allan J. Collins, MD

      Affiliations

    • US Renal Data System, Bethesda, MD
    • ,
  • Catarina I. Kiefe, MD, PhD

      Affiliations

    • Center for Outcomes Effectiveness Research and Education, University of Alabama at Birmingham, Birmingham, AL
    • Department of Medicine, Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL
    • Birmingham Veterans Affairs Medical Center, University of Alabama at Birmingham, Birmingham, AL
    • ,
  • Christopher S. Coffey, PhD

      Affiliations

    • Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, AL.
    • ,
  • David G. Warnock, MD

      Affiliations

    • Department of Medicine, Division of Nephrology, University of Alabama at Birmingham, Birmingham, AL

Received 27 August 2007 ,Accepted 20 March 2008.

References 

  1. Rostand S, Kirk K, Rutsky E, Pate B. Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med. 1982;306:1276–1279
  2. US Renal Data System. USRDS 2006 Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006;
  3. Clase CM, Garg AX, Kiberd BA. Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol. 2002;13:1338–1349
  4. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1–12
  5. Hsu C-y, Lin F, Vittinghoff E, Shlipak MG. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol. 2003;14:2902–2907
  6. Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2005;16:180–188
  7. Trivedi HS, Pang MMH. Discrepancy in the epidemiology of nondiabetic chronic renal insufficiency and end-stage renal disease in black and white Americans: The Third National Health and Nutrition Examination Survey and United States Renal Data System. Am J Nephrol. 2003;23:448–457
  8. Tarver-Carr ME, Powe NR, Eberhardt MS, et al. Excess risk of chronic kidney disease among African American versus white subjects in the United States: A population-based study of potential explanatory factors. J Am Soc Nephrol. 2002;13:2363–2370
  9. Brancati FL, Whittle JC, Whelton PK, Seidler AJ, Klag MJ. The excess incidence of diabetic end-stage renal disease among blacks (A population-based study of potential explanatory factors). JAMA. 1992;268:3079–3084
  10. Newsome BB, McClellan WM, Allison JJ, Kiefe CI, Coffey CS, Warnock DG. African Americans with kidney disease have better survival than whites after acute myocardial infarction. Clin J Am Soc Nephrol. 2006;1:993–1000
  11. Marciniak TA, Ellerbeck EF, Radford MJ, et al. Improving the quality of care for Medicare patients with acute myocardial infarction: Results from the Cooperative Cardiovascular Project. JAMA. 1998;279:1351–1357
  12. Anonymous International Classification of Diseases, Ninth Revision, Clinical Modification. (ed 6). Washington, DC: Public Health Service, US Department of Health and Human Services; 1997;
  13. Canchola JA, Neilands TB, Cantania JA. Imputation Strategies for Sexual Orientation using SAS PROC MI. In the Proceedings of the the Tenth Annual Western Users of SAS Software Conference, San Diego 2002;
  14. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med. 1999;130:461–470
  15. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 1999;11:0828A;(abstr)
  16. Froissart M, Rossert JA, Jacquot C, Paillard M, Houillier P. Predictive performance of the Modification of Diet in Renal Disease and Cockroft-Gault equations for estimating renal function. J Am Soc Nephrol. 2005;16:763–773
  17. Dubois D, Dubois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med. 1916;17:863–871
  18. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  19. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1–S266
  20. Allison JJ, Kiefe CI, Weissman NW, et al. Relationship of hospital teaching status with quality of care and mortality for Medicare patients with acute MI. JAMA. 2000;284:1256–1262
  21. Lane WP, Nelder JA. Analysis of covariance and standardization as instances of prediction. Biometrics. 1982;38:613–621
  22. Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics. 1995;51:524–532
  23. Krumholz HM, Chen J, Wang Y, Radford MJ, Chen YT, Marciniak TA. Comparing AMI mortality among hospitals in patients 65 years of age and older: Evaluating methods of risk adjustment. Circulation. 1999;99:2986–2992
  24. McClellan WM, Warnock DG, McClure LA, et al. Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study. J Am Soc Nephrol. 2006;17:1710–1715
  25. Smith GL, Shlipak MG, Havranek EP, et al. Race and renal impairment in heart failure: Mortality in blacks versus whites. Circulation. 2005;111:1270–1277
  26. Freedman BI, Soucie JM, Kenderes B, et al. Family history of end-stage renal disease does not predict dialytic survival. Am J Kidney Dis. 2001;38:547–552
  27. Ojo AO, Wolfe RA, Agodoa LY, et al. Prognosis following primary renal transplant failure and the beneficial effects of re-transplantation (Multivariate analysis from the U.S. Renal Data System). Transplantation. 1998;66:1651–1659
  28. Melamed ML, Eustace JA, Plantinga L, et al. Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal study. Kidney Int. 2006;70:351–357
  29. Byrne C, Nedelman J, Luke RG. Race, socioeconomic status, and the development of end-stage renal disease. Am J Kidney Dis. 1994;23:16–22
  30. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and white men (16-Year MRFIT findings). JAMA. 1997;277:1293–1298
  31. August P, Suthanthiran M. Transforming growth factor beta and progression of renal disease. Kidney Int. 2003;64(suppl 87):S99–S104
  32. Chen J, Radford MJ, Wang Y, Marciniak TA, Krumholz HM. Do “America's Best Hospitals” perform better for acute myocardial infarction?. N Engl J Med. 1999;340:286–292
  33. Gornick ME, Eggers PW, Reilly TW, et al. Effects of race and income on mortality and use of services among Medicare beneficiaries. N Engl J Med. 1996;335:791–799
  34. Lauderdale DS, Goldberg J. The expanded racial and ethnic codes in the Medicare data files: Their completeness of coverage and accuracy. Am J Public Health. 1996;86:712–716
  35. Pan CX, Glynn RJ, Mogun H, Choodnovsky I, Avorn J. Definition of race and ethnicity in older people in Medicare and Medicaid. J Am Geriatr Soc. 1999;47:730–733
  36. Canto JG, Allison JJ, Kiefe CI, et al. Relation of race and sex to the use of reperfusion therapy in Medicare beneficiaries with acute myocardial infarction. N Engl J Med. 2000;342:1094–1100
  37. He J, Whelton PK. Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease. J Hypertens. 1999;17(suppl 2):S7–S13
  38. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function—Measured and estimated glomerular filtration rate. N Engl J Med. 2006;354:2473–2483

 Originally published online as doi:10.1053/j.ajkd.2008.03.019 on May 14, 2008.

PII: S0272-6386(08)00650-1

doi: 10.1053/j.ajkd.2008.03.019

American Journal of Kidney Diseases
Volume 52, Issue 2 , Pages 251-261 , August 2008

Article Tools

* Image Usage & Resolution